Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Virginia Commonwealth University

12 clinical trials · 12 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Virginia Commonwealth University

RECRUITINGPhase 4NCT06370000

Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality

Test feasibility of an oral maintenance strategy for transplant eligible AML patients in first CR who are medically underserved or have a disadvantage in the CDC SDOH domains

Sponsor: Virginia Commonwealth UniversityEnrolling: 121 location
Acute Myeloid Leukemia
RECRUITINGNCT06989086

FearLess in NeuroOncology

The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize...

Sponsor: Virginia Commonwealth UniversityEnrolling: 1121 location
Primary Malignant Brain TumorGlioblastoma (GBM)Astrocytoma+2
RECRUITINGNCT06682494

Enhancing Oral Cancer Awareness

To evaluate the impact of AI-powered chatbot interactions versus traditional educational handouts on increasing participants' knowledge of oral cancer and its prevention

Sponsor: Virginia Commonwealth UniversityEnrolling: 601 location
Oral CancerChatbotPatient Education+3
RECRUITINGPhase 2NCT06846463

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

This study is a single-arm, open label, non-randomized, phase 2 trial of zanubrutinib in patients with diffuse large B-cell lymphoma (DLBCL) who have an MYD88 L265P mutation, a...

Sponsor: Virginia Commonwealth UniversityEnrolling: 211 location
Diffuse Large B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma
RECRUITINGPhase 2NCT05177822

Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure

Patients who have a heart attack are at high risk for future development of heart failure ('weakening of the heart'). The researchers believe that the reaction of the heart muscle...

Sponsor: Virginia Commonwealth UniversityEnrolling: 842 locations
Heart Failure
RECRUITINGPhase 1 / Phase 2NCT05194111

Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan

To determine feasibility of recruitment and tolerability of treatment with sacubitril-valsartan among adult age survivors of cancer diagnosed at or before age 39 who have stage B...

Sponsor: Virginia Commonwealth UniversityEnrolling: 531 location
Heart FailureHeart Dysfunction
RECRUITINGNCT06861608

A Single-session Intervention Adaptation of the Habit Framework for the Prevention of Eating Disorders

The purpose of this proposal is to launch the first trial of a single-session intervention (SSI) specifically for the prevention of eating disorders (EDs).

Sponsor: Virginia Commonwealth UniversityEnrolling: 1601 location
Eating Disorder Not Otherwise Specified
RECRUITINGNCT05799872

Neuroscience-informed Treatment to Remotely Target Reward Mechanisms in Post-acute Anorexia Nervosa

The investigators will recruit individuals with broadly-defined AN (n = 80) who are currently in or have recently participated in higher-level eating disorder treatment (e.g.,...

Sponsor: Virginia Commonwealth UniversityEnrolling: 901 location
Anorexia Nervosa
RECRUITINGPhase 2NCT06981195

Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects

The goal of this clinical trial is to learn about how certain medications used to treat insomnia (e.g., Lemborexant) impact sleep, mood, and behavior in men and women with Opioid...

Sponsor: Virginia Commonwealth UniversityEnrolling: 1001 location
Opioid Use DisorderOpioid UseInsomnia+1
RECRUITINGPhase 2NCT05424003

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

In this study, semaglutide will be compared to placebo (a look-alike inactive substance, a "sugar pill") to determine if its use will prevent weight gain after liver...

Sponsor: Virginia Commonwealth UniversityEnrolling: 501 location
NAFLD
RECRUITINGPhase 1NCT06062966

The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)

End-stage heart failure (HF) is a progressive illness with a mortality rate similar to most advanced cancers.Roughly 5% of patients with HF have end-stage disease that is...

Sponsor: Virginia Commonwealth UniversityEnrolling: 201 location
Heart Failure
RECRUITINGNCT05989620

Long-Term Development of Muscular Dystrophy Outcome Assessments

This is a 24-month, observational study of up to 1000 participants with Limb Girdle Muscular Dystrophy (LGMD), Myotonic Dystrophy Type 2 (DM2), and late onset Pompe disease (LOPD).

Sponsor: Virginia Commonwealth UniversityEnrolling: 10001 location
LGMD1BLGMD1CLGMD1D+26